Summary
Two Itochu Corp. units are expanding into the business of luring more foreign drug companies to Japan, in a bid to help them develop innovative therapies for the local market that are already available overseas.
Source: Bloomberg
Exclusive AI-Powered News Insights (For Members only)
Disclaimer:This content is AI-generated from various trusted sources and is intended for informational purposes only. While we strive for accuracy, we encourage you to verify details independently. Use the contact button to share feedback on any inaccuracies—your input helps us improve!
